Drug Shortage Report for ISOPROTERENOL HYDROCHLORIDE INJECTION USP

Last updated on 2025-08-05 History
Report ID 263259
Drug Identification Number 00897639
Brand name ISOPROTERENOL HYDROCHLORIDE INJECTION USP
Common or Proper name ISOPROTERENOL HYDROCHLORIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ISOPROTERENOL HYDROCHLORIDE
Strength(s) 0.2MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 1ML 10LIAM
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2025-07-21
Estimated end date 2025-08-08
Actual end date 2025-08-04
Shortage status Resolved
Updated date 2025-08-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-08-05 English Compare
v5 2025-08-04 French Compare
v4 2025-08-04 English Compare
v3 2025-07-22 English Compare
v2 2025-07-21 French Compare
v1 2025-07-21 English Compare

Showing 1 to 6 of 6